Experiences with

Epirubicin

In July 2023 I was diagnosed with low grade, non-muscle invasive (PTa) bladder cancer and had a 12-month treatment with Epirubicin per respective protocol.

My oncologist has given me 3 options, oral Capecitabane or two intravenous options, Epirubicin or Paclitaxel.All obviously have side effects, which depends on the individual, as well as the issue of how long it will give for any quality of life, but after nearly 6 weeks still feeling the after effects

Commenced on 3 weekly epirubicin and cyclophosphamide. I'm on my 2nd cycle but during the 2 cycles I have the most horrendous, unrelenting pain in my upper back area which is also very tender. I have 15mg slow release morphine and more for breakthrough but despite this the pain continues.

It’s been a difficult time for me as my previous 3 IV treatments, taxol, Epirubicin & Eribulin had mixed results & just didn’t attack my pesky liver mets! Part of me even wanted a short treatment break but deep down I knew that wouldn’t be wise! Wishing you all a lovely weekend & stay safe!

Hi I’ve once again received news of liver progression from my latest CT scan following 10 weeks of Epirubicin. My report confirmed a mixed response to treatment with a decrease in size of the left axillary node however an increase in size of the liver metastasis and a new right pleural effusion.

I’m doing ok after 3 weeks of IV Epirubicin - just hope it’s working its magic 🤞 Love Jo xx Cheers 🥂

. 👍 I’m going to give Epirubicin a go starting next week. Let’s hope it’s successful 🤞 I’m fine, had a few tears 😭 & then I get on with enjoying life & can have holiday breaks whenever I want x 👍 🌸💕 Jo xx

However, she has also offered me two other options to consider Epirubicin or an oral drug called Vinorelbine. I am very scared of IV chemo so I’ve been given up to a week to digest things and reach a decision on what to try next.

Epirubicin - once weekly continuous or 3 weekly Vinorelbine - oral day 1 & day 8 - 3 weekly cycle. I’m currently considering my options and Steve and I will visit Steph again on Thursday.

my mother got detected with stage3A BC, er/pr +ve her2 -ve. her 1st chemo started today[epirubicin 50mg; Docitaxel 40mg] current medical onco has not shared the dosage+plan with us. just told us that chemo can be 4 to 6.

You cannot imagine the shock when she laid out her plans for me which consisted of 4 sessions of EC chemo (Epirubicin and Cyclophosphamide) three weeks apart. Followed by 12 weekly doses of Paclitaxol.

Oncologists treated it with 4 neo adjuvant chemos(epirubicin 160mg+cyclophosphamide 1gram dose) cycled by every after 21days.the memograph shown 70-80 % reduction. And now they said for operation to remove the whole right breast,and later they might ask for some more chemos..

She finally started the chemo on 2nd August 2013. 2 Cycles of Epithral + Endoxan + 5 FU on every 21st Day 1 FEC (5 Fluoroacil + Epirubicin + Cyclophosphamide) 3 Cycles of Taxol + Herceptine on every 21st Day 3 Cycles of Herceptine alone on every 21st Day.

They are going with ECX with husband having an overnight stay for the epirubicin and cisplatin, not because of the time it takes, but they want to make sure he has enough liquid inside him so it's easier via a drip.

We have heard that using epirubicin is a potential option, however I am not exactly jumping out of my seat with excitement for this old drug.

The regimen imlemented by our current onco is as follows - 3 Cycles of FEC (5 Fluoroacil + Epirubicin + Cyclophosphamide) + Herceptin every 21 days followed by 3 Cycles of Docetaxel + Herceptin.

Our onco decided to have a neoadjuvant chemo with Docetaxel, epirubicin and endoxan. They call it Nact regime. Her reports including PET shows localised disease with a 5 cm tumor IDC. Though Mri showed some sign in one of the nodes.....i think thats why Dr staged it at 3a.

Two groups of chemotherapy drugs are particularly prone to cause nail changes: Taxanes e.g. docetaxel and paclitaxel Anthracyclines e.g. doxorubicin, idarubicin and epirubicin. Nail changes may also be seen with hydroxyurea.

He is just finishing his 6th cycle of ECX regime having had his last infusion of Cisplatin and Epirubicin 10 days ago, so just 11 days' worth of Capecitabine to finish.

In another European study, 64 of 94 patients with stages IC–IV disease who had undergone "radical" surgery and had no evidence of gross residual disease after six courses of chemotherapy (carboplatin, epirubicin, and prednimustine) were randomized to receive either consolidation WAI (30 Gy), followed